Dutch CDMO Symeres has acquired Exemplify Biopharma, a US-based contract research organization (CRO) based in Cranbury, New Jersey, USA. The deal further strengthens...

The increasing complexity in drug development and the highly competitive industry landscape are creating a dramatic shift in how pharmaceutical and biotech companies plan...

Artificial intelligence (AI) has become one of the supporting pillars for digitalization in many areas of the business world. The pharmaceutical industry and its GxP...

Interview with Marc Doyle, CEO of Arxada, which was created following the carve-out and sale of Lonza Specialty Ingredients to private equity firms Bain Capital and...

Bio-Rad Laboratories is in talks to merge with fellow life-sciences company Qiagen in a deal that could be worth more than $10 billion, US business newspaper Wall Street...

The board of directors at US plant-based synthetic biology company Calyxt is evaluating potential strategic alternatives to maximize shareholder value, the company...

Chemical parks are locations of intensive value creation. They are a driver for sustainable development with a high economic, ecological and social impact.

Swiss-based and Chinese-owned agrochemicals company Syngenta has entered into a global commercial and R&D collaboration with Bioceres, a US-based provider of biological...